Back to Search
SIGMUND TANNENBAUM, MD
MD
Urology Physician
NPI: 1225024540IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
20977(NC)
CMS Specialties
PrimaryUROLOGY
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 1975
Research & Publications (20)
Liver tissue engineering in the evaluation of drug safety.
PMID 19637986·Expert Opin Drug Metab Toxicol·2009
6-review
Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma.
PMID 19660004·Br J Clin Pharmacol·2009
4-observational
Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations.
PMID 19130931·J Allergy Clin Immunol·2009
4-observational
Mechanical injury and cytokines cause loss of cartilage integrity and upregulate proteins associated with catabolism, immunity, inflammation, and repair.
PMID 19196708·Mol Cell Proteomics·2009
7-preclinical
Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice.
PMID 19164562·Proc Natl Acad Sci U S A·2009
7-preclinical
Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization.
PMID 18813360·Neoplasia·2008
3-trial
A sodium dodecyl sulfate-polyacrylamide gel electrophoresis-liquid chromatography tandem mass spectrometry analysis of bovine cartilage tissue response to mechanical compression injury and the inflammatory cytokines tumor necrosis factor alpha and interleukin-1beta.
PMID 18240213·Arthritis Rheum·2008
7-preclinical
Monitoring in vivo metabolism and elimination of the endogenous DNA adduct, M1dG {3-(2-deoxy-beta-D-erythro-pentofuranosyl)pyrimido[1,2-alpha]purin-10(3H)-one}, by accelerator mass spectrometry.
PMID 18461974·Chem Res Toxicol·2008
7-preclinical
Integration of continuous-flow accelerator mass spectrometry with chromatography and mass-selective detection.
PMID 18494504·Anal Chem·2008
7-preclinical
Increase of reaction rate and sensitivity of low-abundance enzyme assay using micro/nanofluidic preconcentration chip.
PMID 18358012·Anal Chem·2008
8-other
Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants.
PMID 17923423·Osteoarthritis Cartilage·2008
7-preclinical
Analysis of DNA adducts formed in vivo in rats and mice from 1,2-dibromoethane, 1,2-dichloroethane, dibromomethane, and dichloromethane using HPLC/accelerator mass spectrometry and relevance to risk estimates.
PMID 17907789·Chem Res Toxicol·2007
7-preclinical
Identification of adducts formed by reaction of N-acetoxy-3,5-dimethylaniline with DNA.
PMID 18020398·Chem Res Toxicol·2007
8-other
Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice.
PMID 17388619·J Proteome Res·2007
7-preclinical
Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression.
PMID 17419948·Adv Cancer Res·2007
6-review
Optical tomography with ultrasound localization for breast cancer diagnosis and treatment monitoring.
PMID 17560514·Surg Oncol Clin N Am·2007
6-review
Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
PMID 17671226·Cancer Res·2007
4-observational
Covalent adducts arising from the decomposition products of lipid hydroperoxides in the presence of cytochrome c.
PMID 17407328·Chem Res Toxicol·2007
8-other
A patterned anisotropic nanofluidic sieving structure for continuous-flow separation of DNA and proteins.
PMID 18654231·Nat Nanotechnol·2007
8-other
Application of liquid chromatography-accelerator mass spectrometry (LC-AMS) to evaluate the metabolic profiles of a drug candidate in human urine and plasma.
PMID 19356047·Drug Metab Lett·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 509 N ELAM AVE FL 2
GREENSBORO, NC 27403 - Phone
- (336) 274-1114
Quick Facts
- NPI
- 1225024540
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 51
- Publications
- 20
Are you this provider?
Claim Your Profile